National cost-sharing caps may help reduce out-of-pocket insulin spending, but further action is still required

Written by Ilana Landau, Editor

New research suggests that the introduction of national cost-sharing caps for insulin may help improve its affordability for privately insured children and young adults with Type 1 diabetes in the USA, however, more effective policies to address high insulin costs are still required. Insulin is an essential medicine used in the management of diabetes, however, high – and rising –  drug costs mean it is unaffordable for many patients, which has caused some to even resort to rationing it, resulting in poor blood glucose control. In a Research Letter published in JAMA Pediatrics, investigators from the University of Michigan (MI,...

To view the full article, please register now for access

It's completely free